Long-Term Outcome After Postmastectomy Radiation Therapy for the Treatment of Ductal Carcinoma in Situ of the Breast
Phase II Trial of Topotecan in Advanced Breast Cancer
Renal Cell Carcinoma
Bulky, Barrel-Shaped Cervical Carcinoma (Stages IB, IIA, IIB)
Mature Results From a Phase II Trial of Accelerated Induction Chemoradiotherapy and Surgery for Poor Prognosis Stage III Non-Small-Cell Lung Cancer
Diffuse Malignant Leptomeningeal Gliomatosis in a Child
Marimastat in Patients With Advanced Pancreatic Cancer
Adjuvant (Cisplatin, Etoposide, and 5-Fluorouracil) Chemotherapy After Curative Resection of Gastric Adenocarcinomas Involving the Esophagogastric Junction
Phase III Controlled Evaluation of Glutamine for Decreasing Stomatitis in Patients Receiving Fluorouracil (5-FU)-Based Chemotherapy
Epirubicin, Folinic Acid, Fluorouracil, and Etoposide in the Treatment of Advanced Gastric Cancer
Phase I-II Trial of Intensification of the MAID Regimen With Support of Lenograstim (rHuG-CSF) in Patients With Advanced Soft-Tissue Sarcoma (STS)
First-Line Treatment With Mitoxantrone, Methotrexate, Vincristine, and Carboplatine (MIMOC) Plus Cyclical Hormonotherapy With Tamoxifen and Megestrol Acetate in Advanced Breast Cancer
Variations of p53 in Cultured Fibroblasts of Patients With Lung Cancer Who Have a Presumed Genetic Predisposition
Non-Hodgkin Lymphoma and Coexisting Primary Cancers
Palliative Treatment of Epidemic Kaposi Sarcoma of the Feet
Phase II Evaluation of Treatment of Complete Resection of Hepatic Metastases From Colorectal Cancer and Adjuvant Hepatic Arterial Infusion of Floxuridine
Short-Term Intensive Consolidation Therapy After All-Trans Retinoic Acid in Acute Promyelocytic Leukemia
Combination Cisplatin-Vinorelbine for Relapsed and Chemotherapy-Pretreated Metastatic Breast Cancer
Bone Marrow Relapse in Primary Mucinous Carcinoma of Skin
Cisplatin Ototoxicity
Combined Chemoradiotherapy for Unresectable Pancreatic Cancer
Extrahepatic Regional Chemotherapy
Carcinoma of the Stomach Metastatic to the Liver That Progressed After Hepatic Arterial Infusion of Cisplatin Plus 5-Floxuridine, and Then Dramatically Regressed After Chemoembolization Based on Positive Chromogranin Staining